Source: ERS Course 2016
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Vasakova (Prague, Czech Republic). Managing end stage disease in ILDs. ERS Course 2016

Member's Comments

No comment yet.

Related content which might interest you: Treatment of advanced CF lung disease and end of life care Source: ERS course 2015 Year: 2015 Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Evaluating the effects of pulmonary rehabilitation in patients with COPD in early and late disease stages. Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Association of caregiver burden and depression in caregivers of patients with chronic respiratory failure secondary to advanced and end stage lung disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning? Source: Eur Respir J 2011; 37: 489-491 Year: 2011 Symptoms management of advanced lung disease Source: Annual Congress 2004 - Palliative care in lung disease Year: 2004 Treatment of advanced cystic fibrosis lung disease and end of life decisions Source: School Course 2013 - Cystic Fibrosis Year: 2013 COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Empyema: How to prevent progression to stage III disease Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques Year: 2019 Empyema: How to prevent progression to stage III disease Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques, April 2019 Year: 2019 Empyema: How to prevent progression to stage III disease Source: ERS Skills Course 2018 - Thoracoscopy and pleural techniques Year: 2018 Monitoring disease progression in COPD patients: one step beyond! Source: Eur Respir J 2014; 43: 665-667 Year: 2014 How to prevent progression to stage III disease Source: International Congress 2016 – An update on pleural empyema diagnostics and treatment Year: 2016 Delay in diagnosis of COPD leading to poor prognosis of disease Source: International Congress 2015 – Different data in COPD Year: 2015 Challenging infections in advanced CF lung disease Source: Annual Congress 2013 –Challenges in lung transplantation for cystic fibrosis Year: 2013 Markers of early disease and prognosis in COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Features affecting stages of patients with lung cancer at diagnosis Source: Eur Respir J 2005; 26: Suppl. 49, 536s Year: 2005 Do nocturnal apnoeas contribute to increased cardiovascular risk in end stage renal disease patients? Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017